Charles Schwab
TMO icon

Charles Schwab’s Thermo Fisher Scientific TMO Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.22B Buy
3,000,562
+74,971
+3% +$30.4M 0.21% 82
2025
Q1
$1.46B Buy
2,925,591
+115,463
+4% +$57.5M 0.27% 64
2024
Q4
$1.46B Buy
2,810,128
+366,191
+15% +$191M 0.27% 59
2024
Q3
$1.51B Buy
2,443,937
+61,017
+3% +$37.7M 0.29% 56
2024
Q2
$1.32B Buy
2,382,920
+34,501
+1% +$19.1M 0.25% 71
2024
Q1
$1.36B Buy
2,348,419
+71,153
+3% +$41.4M 0.32% 54
2023
Q4
$1.21B Buy
2,277,266
+92,338
+4% +$49M 0.31% 60
2023
Q3
$1.11B Buy
2,184,928
+8,672
+0.4% +$4.39M 0.32% 55
2023
Q2
$1.14B Sell
2,176,256
-15,340
-0.7% -$8M 0.32% 53
2023
Q1
$1.26B Buy
2,191,596
+38,612
+2% +$22.3M 0.38% 41
2022
Q4
$1.19B Buy
2,152,984
+62,495
+3% +$34.4M 0.38% 45
2022
Q3
$1.06B Buy
2,090,489
+30,253
+1% +$15.3M 0.38% 49
2022
Q2
$1.12B Buy
2,060,236
+14,667
+0.7% +$7.97M 0.39% 47
2022
Q1
$1.21B Buy
2,045,569
+32,043
+2% +$18.9M 0.36% 45
2021
Q4
$1.34B Buy
2,013,526
+47,206
+2% +$31.5M 0.4% 42
2021
Q3
$1.12B Buy
1,966,320
+21,189
+1% +$12.1M 0.37% 53
2021
Q2
$981M Buy
1,945,131
+47,449
+3% +$23.9M 0.33% 60
2021
Q1
$866M Buy
1,897,682
+14,398
+0.8% +$6.57M 0.32% 61
2020
Q4
$877M Sell
1,883,284
-32,193
-2% -$15M 0.35% 53
2020
Q3
$846M Buy
1,915,477
+48,950
+3% +$21.6M 0.39% 50
2020
Q2
$676M Sell
1,866,527
-10,874
-0.6% -$3.94M 0.33% 56
2020
Q1
$532M Buy
1,877,401
+5,459
+0.3% +$1.55M 0.31% 63
2019
Q4
$608M Buy
1,871,942
+26,617
+1% +$8.65M 0.33% 52
2019
Q3
$537M Buy
1,845,325
+48,566
+3% +$14.1M 0.32% 56
2019
Q2
$528M Buy
1,796,759
+40,204
+2% +$11.8M 0.32% 55
2019
Q1
$481M Buy
1,756,555
+119,201
+7% +$32.6M 0.31% 61
2018
Q4
$366M Buy
1,637,354
+42,021
+3% +$9.4M 0.28% 65
2018
Q3
$389M Buy
1,595,333
+28,770
+2% +$7.02M 0.26% 70
2018
Q2
$324M Buy
1,566,563
+46,519
+3% +$9.64M 0.24% 74
2018
Q1
$314M Sell
1,520,044
-8,536
-0.6% -$1.76M 0.24% 70
2017
Q4
$290M Sell
1,528,580
-42,085
-3% -$7.99M 0.23% 74
2017
Q3
$297M Buy
1,570,665
+33,606
+2% +$6.36M 0.26% 63
2017
Q2
$268M Buy
1,537,059
+135,068
+10% +$23.6M 0.25% 66
2017
Q1
$215M Buy
1,401,991
+48,941
+4% +$7.52M 0.22% 80
2016
Q4
$191M Buy
1,353,050
+35,121
+3% +$4.96M 0.21% 84
2016
Q3
$210M Buy
1,317,929
+49,886
+4% +$7.93M 0.25% 66
2016
Q2
$187M Buy
1,268,043
+159,131
+14% +$23.5M 0.23% 70
2016
Q1
$157M Buy
1,108,912
+57,709
+5% +$8.17M 0.21% 89
2015
Q4
$149M Buy
1,051,203
+39,952
+4% +$5.67M 0.2% 93
2015
Q3
$124M Buy
1,011,251
+24,034
+2% +$2.94M 0.18% 109
2015
Q2
$128M Buy
987,217
+13,215
+1% +$1.71M 0.18% 109
2015
Q1
$131M Buy
974,002
+40,944
+4% +$5.5M 0.18% 108
2014
Q4
$117M Buy
933,058
+47,190
+5% +$5.91M 0.18% 118
2014
Q3
$108M Buy
885,868
+21,625
+3% +$2.63M 0.18% 118
2014
Q2
$102M Sell
864,243
-187,373
-18% -$22.1M 0.17% 117
2014
Q1
$126M Buy
1,051,616
+114,316
+12% +$13.7M 0.23% 84
2013
Q4
$104M Sell
937,300
-682,909
-42% -$76M 0.2% 105
2013
Q3
$150M Sell
1,620,209
-318,892
-16% -$29.6M 0.31% 63
2013
Q2
$167M Buy
+1,939,101
New +$167M 0.37% 47